Condition: Epilepsy · Seizure · Sponsor: University of Central Florida
This study aims to examine whether the AI-personalized version of the Medilepsy® app is more effective than the non-AI (standard version without AI personalization) can improve key outcomes, such as medical adherence and transition readiness, among underserved adolescents and young adults with epilepsy, ages 14-24, in Florida, USA. Outcomes are organized into primary (effectiveness), secondary (usability), and exploratory (language experience) endpoints.
This description comes directly from the study's public registry record.
Michelle Tall, PhD, RN, FAES · 4077970555 · Michelle.Tall@UCF.edu
Amoy Fraser, PhD, CCRP, PMP · 4072668742 · Amoy.Fraser@UCF.edu
Always discuss trial participation with your own doctor first.
| Orlando Health Arnold Palmer Hospital | Orlando, Florida, United States | Recruiting |
| Orlando Health Orlando Regional Medical Center | Orlando, Florida, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07445074